HUTCHMED (China) (HCM) Asset Writedowns and Impairment (2015)
HUTCHMED (China)'s (HCM) quarterly Asset Writedowns and Impairment came in at $1.3 million in Q4 2015.
HUTCHMED (China) (HCM) Asset Writedowns and Impairment (2015) Analysis & Trends
HUTCHMED (China) (HCM) has 1 years of Asset Writedowns and Impairment data on file, last reported at $1.3 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.39 Bn | 30.45 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 18.00 Bn | 16.69 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 9.61 Bn | 9.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 1.32 Mn |
| Dec 31, 2015 | 1.32 Mn |